We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$3.74B
AUM Growth
-$335M
Cap. Flow
-$614M
Cap. Flow %
-16.42%
Top 10 Hldgs %
21.69%
Holding
674
New
53
Increased
215
Reduced
238
Closed
121

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$113M
2
INTC icon
Intel
INTC
+$61.2M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$25.3M
4
CLX icon
Clorox
CLX
+$25.2M
5
TJX icon
TJX Companies
TJX
+$24.2M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$107M
2
AAPL icon
Apple
AAPL
+$71.8M
3
TRV icon
Travelers Companies
TRV
+$27.6M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$27.4M
5
AXP icon
American Express
AXP
+$26.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.7%
2 Financials 10.88%
3 Technology 9.76%
4 Communication Services 9.34%
5 Consumer Staples 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMO icon
176
Thermo Fisher Scientific
TMO
$211B
$4.91M 0.13%
34,630
-47,913
-58% -$6.39M
EWC icon
177
iShares MSCI Canada ETF
EWC
$6.04B
$4.88M 0.13%
227,136
– –
NWL icon
178
Newell Brands
NWL
$2.16B
$4.87M 0.13%
+110,536
New +$4.84M
IBM icon
179
IBM
IBM
$202B
$4.7M 0.13%
35,749
-19,635
-35% -$2.64M
RY icon
180
Royal Bank of Canada
RY
$291B
$4.67M 0.13%
87,558
-11,165
-11% -$626K
FPRX
181
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$4.62M 0.12%
111,300
+14,000
+14% +$469K
ADT
182
DELISTED
ADT Corp
ADT
$4.6M 0.12%
139,457
+130,876
+1,525% +$4.4M
AET
183
DELISTED
Aetna Inc
AET
$4.59M 0.12%
42,501
-135,422
-76% -$14.6M
MA icon
184
Mastercard
MA
$477B
$4.59M 0.12%
47,116
-4,601
-9% -$451K
GHDX
185
DELISTED
Genomic Health, Inc.
GHDX
$4.51M 0.12%
128,000
-46,400
-27% -$1.24M
KMI icon
186
Kinder Morgan
KMI
$73.1B
$4.49M 0.12%
300,837
+215,333
+252% +$5.13M
NEM icon
187
Newmont
NEM
$98.2B
$4.49M 0.12%
249,353
+168,657
+209% +$3.1M
SAGE
188
DELISTED
Sage Therapeutics
SAGE
$4.44M 0.12%
76,200
+10,000
+15% +$495K
PGR icon
189
Progressive
PGR
$124B
$4.42M 0.12%
138,859
-7,422
-5% -$236K
ETR icon
190
Entergy
ETR
$54.1B
$4.37M 0.12%
127,810
-8,282
-6% -$278K
WRK
191
DELISTED
WestRock Company
WRK
$4.27M 0.11%
103,839
+30,556
+42% +$1.39M
MGNX icon
192
MacroGenics
MGNX
$235M
$4.18M 0.11%
135,100
+29,000
+27% +$881K
MON
193
DELISTED
Monsanto Co
MON
$4.16M 0.11%
42,187
+28,366
+205% +$2.66M
RRC icon
194
Range Resources
RRC
$9.11B
$4.14M 0.11%
168,305
-44,991
-21% -$1.34M
SO icon
195
Southern Company
SO
$110B
$4.13M 0.11%
88,165
+59,286
+205% +$2.69M
MO icon
196
Altria Group
MO
$122B
$4.09M 0.11%
70,351
+12,655
+22% +$733K
TD icon
197
Toronto Dominion Bank
TD
$198B
$4.07M 0.11%
104,294
-11,791
-10% -$477K
YUM icon
198
Yum! Brands
YUM
$41B
$4.06M 0.11%
77,344
+63,850
+473% +$3.34M
CEMP
199
DELISTED
Cempra, Inc.
CEMP
$4.05M 0.11%
130,000
-23,500
-15% -$654K
PTLA
200
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$4.02M 0.11%
78,100
+10,000
+15% +$485K
6 7
8
9 10

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2015 Portfolio in Review

As of Q4 2015, Candriam SCA held 674 positions worth $3.74B, down 8.2% from $4.07B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA withdrew a net $614M in Q4 2015, closing 121 positions and reducing 238 holdings. Its most notable exit was Amgen, an estimated $107M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in Alphabet (Google) Class A worth $118M.

  • Candriam SCA's largest Q4 2015 buy was Alphabet (Google) Class A: 3,043,280 shares worth $118M.
  • Candriam SCA added most to Intel in Q4 2015, an estimated $61.2M increase.
  • Candriam SCA's biggest Q4 2015 reduction was Colgate-Palmolive, cutting an estimated $21.3M.
  • Candriam SCA fully exited Amgen in Q4 2015, selling an estimated $107M.
  • Candriam SCA's ten largest holdings make up 22% of its $3.74B portfolio in Q4 2015.
  • Candriam SCA opened 53 new positions and closed 121 in Q4 2015.
  • Candriam SCA's portfolio value fell 8.2% quarter-over-quarter to $3.74B.

Based on Candriam SCA's 13F filing for Q4 2015, filed 25 Jan 2016.